Publications

2026 | Blood Advances

Sorror ML, Saber W, Logan B, et al. Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704. Blood Adv. 2025;9(13):3268-3280.

Authors:

Sorror, ML, Saber, W, Logan, BR, Geller, N, Bellach, A, Kou, J, Wood, W, McCarty, JM, Knight, TG, Runaas, L, Johnston, L, Walston, J, Nakamura, R, Jarrett, L, Mishra, A, Uberti, J, Dahi, PB, Saultz, JN, McCurdy, SR, Morris, LE, Imus, PH, Hogan, WJ, Nadiminti, K, Bhatt, VR, Olin, R, Maakaron, J, Sobecks, R, Wall, SA, Mattila, D, Protz, B, Devine, SM, Horowitz, MM, Artz, AS

2026 | Bone Marrow Transplantation

Clinical risk factors alone do not predict the development of moderate-severe chronic graft-versus-host disease after hematopoietic cell transplantation and post-transplant cyclophosphamide.

Authors:

Im A, Wang T, DeFilipp Z, Farhadfar N, El Jurdi N, Khandelwal P, Kitko CL, Devos J, Castillo P, Ganguly S, Grunwald MR, Hamilton BK, Hashem H, Jamy O, Rangarajan HG, Kharfan-Dabaja MA, Yared JA, Williams KM, William BM, Spellman SR, Lee SJ, Pavletic S

2026 | Transplantation and Cellular Therapy

Corrigendum to choosing between HLA-mismatched unrelated and haploidentical donors: Donor age considerations.

Authors:

Mehta RS, Schmidt G, Williams K, Patel SA, Schetelig J, Savani B, Askar M, Petersdorf E, Ringden O, Kanakry CG, Kanakry JA, Stefanski H, Arrieta-Bolaños E, Betts B, Benjamin C, Gadalla S, Wang T, Saultz J, Spellman S, Jurdi NE, Bolon YT, Lee SJ

2026 | Blood Advances

Reduced-intensity haploidentical bone marrow transplantation in children with severe sickle cell disease: BMT CTN 1507.

Authors:

Walters MC, Kassim AA, Eapen M, Jordan LC, Pruthi S, Greene EB, Smith M, Milner J, Nickel RS, Bollard CM, Gillio AP, Yassine K, Skiles J, McKinney CM, Rangarajan HG, Abusin G, Yanik GA, Galvez Silva JR, Kent M, Ritzau N, Mendizabal AM, Mahadeo KMM, Krishnamurti L, Cooke KR, Leifer E, Logan BR, Horowitz MM, Jones RJ, Brodsky RA, DeBaun MR

2026 | Journal of the National Comprehensive C...

Factors associated with clinical trial participation in hematopoietic stem cell transplantation (HSCT) recipients: A CIBMTR analysis.

Authors:

Fowler TF, Brazauskas R, Patel J, Rangarajan HG, Michelis FV, Battiwalla M, Lehmann LE, Stefanski HE, Dias AL, Sharma A, Beitinjaneh A, Zeidan AM, Gómez-De León A, Saad A, Hamilton BK, Marks DI, Rizzieri DA, Szwajcer D, Lad DP, Hildebrandt GC, Hashem H, Murthy HS, Liu H, Preussler JM, Yared JA, Aljurf M, de Lima M, Krem MM, Herr MM, Solh M, 31. Abid MB, Ramanathan M, El Jurdi N, Khera N, Majahil NS, Lulla P, Seo S, Hong S, Chhabra S, Ganguly S, Gergis U, Agrawal V, El-Jawahri AR, Saber W

2026 | Science Translational Medicine

Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant.

Authors:

DeWolf S, Siegel SJ, Schmalz J, Saber W, Albanese A, Dong J, Martens MJ, Logan B, Iovino L, Ingersoll-Ohmdahl, K, Winn, N, Chen E, Kaminski J, Neuberg D, Hebert K, Keskula P, Zavistaski J, Steinberg L, Schichter I, Katsamakis, Z, Cagnin L, Hernandez V, Warren M, Applegate K, Bar M, Chhabra S, Choi SW, Clark W, Das S, Jenq R, Jones RJ, Levine JE, Murthy H, Rashidi A, Riches M, Sandhu K, Sung AD, Larkin K, Al Malki MM, Gooptu M, Elmariah H, Alousi A, Runaas L, Shaffer B, Rezvani AR, El Jurdi N, Loren AW, Scheffey D, Sanders C, Hamadani M, Dudakov J, Bien S, Robins H, Horowitz MM, Bolanos-Meade J, Holtan SG, Bhatt AS, Perales MA, Kean L

2026 | Blood Advances

Hematopoietic cell transplantation outcomes in the era of post‑transplant Cyclophosphamide: comprehensive donor analysis.

Authors:

Aljawai YM, Ueda Oshima M, Astha V, Litvinovich I, He M, Layton SA, Bupp C, Ahn KW, Bolaños-Meade J, Gooptu M, Lazaryan A, Al Malki MM, Stefanski HE, Shaw BE, Spellman SR, Auletta JJ, Devine SM, Juckett MB, Elmariah H

2026 | Blood

Germline DDX41 defines a distinct subgroup in MDS undergoing transplantation with reduced relapse and improved survival.

Authors:

Gagelmann N, Reilly CR, Sasi A, Hebert K, Auer P, Dong J, Zhang T, Wang T, Cutler CS, Soiffer RJ, Spellman SR, Saber W, Lindsley RC

2026 | Cancer

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis.

Authors:

Mian H, Faisal MS, Chen T, Brazauskas R, Oloyede T, Ahmed N, Afrough A, Anderson LD, Banerjee R, Berdeja J, Bidikian A, Devos J, Dhakal B, Diaz A, Dima D, Efebera YA, Gowda L, Hansen DK, Hashmi H, Landau HJ, Lekakis L, Mirza AS, Narra R, Patel K, Rosko AE, Schroeder M, Sidana S, Usmani S, Pasquini MC, Nishihori T, Akhtar OS, Mohan M

2026 | Journal of Hematology & Oncology

Mitochondrial genetic variation as a novel predictor of graft-versus-host disease after stem-cell transplantation in myelodysplastic neoplasms.

Authors:

Arsang-Jang S, Zhang T, Rafati M, Bolon YT, Spellman SR, Chen Z, Jones K, Liu J, Jurdi NE, Gai X, Urrutia R, Gadalla SM, Auer PL, Saber W, Dong J

2026 | Bone Marrow Transplantation

ATG exposure in T replete transplant for hematological malignancies: Real world analysis from BMT CTN 1202.

Authors:

Lakkaraja, M, Mauguen, A, Hosszu, K, McAvoy, D, Stewart, V, Schmidt, G, Levine, JE, Perales, MA, Giralt, SA, Baker, KS, Boelens, JJ

2026 | Transplantation and Cellular Therapy

Trends and predictors of hematopoietic cell transplant utilization for human immunodeficiency virus-lymphoma in California, 1991 to 2016.

Authors:

David KA, Brunson A, Fauer AJ, Schonfeld SJ, Chen S, Zepf R, Fejerman L, Meyer C, Auletta JJ, Muffly L, Morton LM, Catz SL, Keegan THM

2026 | Transplantation and Cellular Therapy

Differences in hematopoietic cell transplantation outcomes by human immunodeficiency virus status, California, 1991 to 2016.

Authors:

David KA, Brunson A, Schonfeld SJ, Fauer AJ, Chen S, Zepf R, Fejerman L, Meyer C, Auletta JJ, Muffly L, Morton LM, Catz SL, Keegan THM

2026 | Cancer Medicine

Mitochondrial genomic alterations in pediatric acute lymphoblastic leukemia: Implications for methotrexate-induced neurotoxicity and ethnic disparities.

Authors:

Han J, Arsang-Jang S, Auer PL, Saber W, Michaelis L, Urrutia R, Gai X, Lupo P, Scheurer M, Dong J

2026 | Journal of Clinical Oncology

Erratum: Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after mismatched unrelated donor peripheral blood stem cell transplantation.

Authors:

Al Malki MM, Bo-Subait S, Logan B, Olson J, Kou J, Smith S, Lekrone E, Wu J, Stefanski HE, Auletta JJ, Spellman SR, Malmberg C, Askar M, Cusatis R, Shaffer BC, Modi D, Khimani F, Gooptu M, Hamadani M, Madbouly A, Maiers M, Fingerson S, Cook R, Ballen K, Loren A, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Shaw BE, Devine SM, Jimenez Jimenez AM

2026 | British Journal of Haematology

Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma.

Authors:

Awan FT, Liu R, Huang HH, Bye M, Ahn KW, Krigsfeld G, Raz A, Wolfe H, Hamadani M

2026 | Blood Cancer Journal

Correction: Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Authors:

Hansen DK, Dima D, Mian H, Devos J, Brazauskas R, Oloyede T, Afrough A, Ahmed N, Anderson LD Jr., Banerjee R, Berdeja JG, Bidikian A, Dhakal B, Dias A, Efebera Y, Faisal MS, Gowda L, Hashmi H, Mirza AS, Mohan M, Narra R, Rosko AE, Schroeder M, Nishihori T, Landau H, Usmani S, Pasquini MC, Akhtar OS, Sidana S, Patel KK

2026 | American Journal of Hematology

Phase II study of posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis after HLA-mismatched unrelated donor reduced intensity transplantation: Results from the ACCESS trial expansion cohort.

Authors:

Schaffer BC, Al Malki MM, Jimenez AMJ, Stanek J, Bo-Subait S, Logan BR, Kou J, Leckrone E, Stefanski HE, Spellman SR, Malmberg C, Askar M, Cusatis R, Modi D, Khimani F, Hamadani M, Maiers M, Cook R, Ballen K, Bolaños-Meade J, Rao U, Milner J, Abboud R, Jamieson K, Carrum G, Dholaria B, Hogan WJ, Reshef R, Kosuri S, Loren A, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Auletta JJ, Shaw BE, Devine SM, Gooptu M

2026 | Blood Advances

Interpreting cord blood transplant outcomes in BMT CTN 1702.

Authors:

Das, R, Scaradavou, A, Barker, J, Fingrut, WB

2026 | Blood Advances

Patient-reported outcomes in clinical trials: Lessons from the Blood and Marrow Transplant Clinical Trials Network.

Authors:

Hamilton, BK, Lee, CJ, Mattila, D, El-Jawahri, A, Cusatis, R, Brazauskas, R, Sung, AD, Phelan, R, Horowitz, MM, Lee, SJ